0002115201-26-000001.txt : 20260311 0002115201-26-000001.hdr.sgml : 20260311 20260311131628 ACCESSION NUMBER: 0002115201-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260311 DATE AS OF CHANGE: 20260311 EFFECTIVENESS DATE: 20260311 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DNA SEQ 2, INC. CENTRAL INDEX KEY: 0002115201 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-576158 FILM NUMBER: 26742550 BUSINESS ADDRESS: STREET 1: 1255 E VISTA WAY #157 CITY: VISTA STATE: CA ZIP: 92084 BUSINESS PHONE: 585-987-2800 MAIL ADDRESS: STREET 1: 1255 E VISTA WAY #157 CITY: VISTA STATE: CA ZIP: 92084 D 1 primary_doc.xml X0708 D LIVE 0002115201 DNA SEQ 2, INC. 1255 E VISTA WAY #157 VISTA CA CALIFORNIA 92084 585-987-2800 DELAWARE None None Corporation true 2022 Andrew Nappin 1255 E Vista Way #157 Vista CA CALIFORNIA 92084 Executive Officer Stuart E. Siegel 1255 E Vista Way #157 Vista CA CALIFORNIA 92084 Director Janusz Maria Sowadski 1255 E Vista Way #157 Vista CA CALIFORNIA 92084 Director Eric Ladizinsky 1255 E Vista Way #157 Vista CA CALIFORNIA 92084 Director Thomas M. Wheeler 1255 E Vista Way #157 Vista CA CALIFORNIA 92084 Director Benjamin Anderson 1255 E Vista Way #157 Vista CA CALIFORNIA 92084 Director Pharmaceuticals Decline to Disclose 06b false 2024-04-10 false true false 0 1176300 1176300 0 false 32 0 0 0 false DNA SEQ 2, INC. /s/ Andrew Nappin Andrew Nappin CEO 2026-03-11